SEC Filing Summary for BioAtla, Inc. - Officer Transaction

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reported a transaction on August 31, 2026, involving 134 shares of Common Stock. The transaction code "F" indicates that this was not a direct sale of shares. Instead, these shares were withheld by the issuer to cover income tax and withholding obligations related to the vesting and net settlement of restricted stock units. Following this transaction, Mr. Sievers owns 11,346 shares of BioAtla, Inc. common stock. The transaction price was reported as $1.69 per share.